BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 28960520)

  • 1. Use of reflectance confocal microscopy to evaluate 5-fluorouracil 0.5%/salicylic acid 10% in the field-directed treatment of subclinical lesions of actinic keratosis: subanalysis of a Phase III, randomized, double-blind, vehicle-controlled trial.
    Ulrich M; Reinhold U; Falqués M; Rodriguez Azeredo R; Stockfleth E
    J Eur Acad Dermatol Venereol; 2018 Mar; 32(3):390-396. PubMed ID: 28960520
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo reflectance confocal microscopy characterization of field-directed 5-fluorouracil 0.5%/salicylic acid 10% in actinic keratosis.
    Ulrich M; Alarcon I; Malvehy J; Puig S
    Dermatology; 2015; 230(3):193-8. PubMed ID: 25721522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment monitoring of 0.5% 5-fluorouracil and 10% salicylic acid in clinical and subclinical actinic keratoses with the combination of optical coherence tomography and reflectance confocal microscopy.
    Malvehy J; Alarcon I; Montoya J; Rodríguez-Azeredo R; Puig S
    J Eur Acad Dermatol Venereol; 2016 Feb; 30(2):258-65. PubMed ID: 26538346
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low-dose 5-fluorouracil in combination with salicylic acid as a new lesion-directed option to treat topically actinic keratoses: histological and clinical study results.
    Stockfleth E; Kerl H; Zwingers T; Willers C
    Br J Dermatol; 2011 Nov; 165(5):1101-8. PubMed ID: 21517801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and Safety of 5-Fluorouracil 0.5%/Salicylic Acid 10% in the Field-Directed Treatment of Actinic Keratosis: A Phase III, Randomized, Double-Blind, Vehicle-Controlled Trial.
    Stockfleth E; von Kiedrowski R; Dominicus R; Ryan J; Ellery A; Falqués M; Ivanoff N; Azeredo RR
    Dermatol Ther (Heidelb); 2017 Mar; 7(1):81-96. PubMed ID: 27995485
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low-Dose 0.5% 5-Fluorouracil/10% Salicylic Acid Topical Solution in the Treatment of Actinic Keratoses.
    Herranz P; Morton C; Dirschka T; Azeredo RR; Roldán-Marín R
    J Cutan Med Surg; 2016 Nov; 20(6):555-561. PubMed ID: 27443886
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of topical piroxicam and sun filters in actinic keratosis evolution and field cancerization: a two-center, assessor-blinded, clinical, confocal microscopy and dermoscopy evaluation trial.
    Agozzino M; Russo T; Franceschini C; Mazzilli S; Garofalo V; Campione E; Bianchi L; Milani M; Argenziano G
    Curr Med Res Opin; 2019 Oct; 35(10):1785-1792. PubMed ID: 31148490
    [No Abstract]   [Full Text] [Related]  

  • 8. A prospective randomized exploratory study comparing the efficacy of once-daily topical 0.5% 5-fluorouracil in combination with 10.0% salicylic acid (5-FU/SA) vs. cryosurgery for the treatment of hyperkeratotic actinic keratosis.
    Simon JC; Dominicus R; Karl L; Rodríguez R; Willers C; Dirschka T
    J Eur Acad Dermatol Venereol; 2015 May; 29(5):881-9. PubMed ID: 25257941
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo Confocal Laser Microscopy for monitoring of actinic keratosis treatment: a comparison with histopathologic assessment after treatment with topical 5% 5-fluorouracil.
    Ishioka P; Maia M; Rodrigues SB; Lellis RF; Hirata SH
    J Eur Acad Dermatol Venereol; 2018 Jul; 32(7):1155-1163. PubMed ID: 29178474
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Controlled Comparison Study of Topical Fluourouracil 5% Cream Pre-Treatment of Aminolevulinic Acid/Photodynamic Therapy for Actinic Keratosis.
    Tanghetti EA; Hamann C; Tanghetti M
    J Drugs Dermatol; 2015 Nov; 14(11):1241-4. PubMed ID: 26580872
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relative efficacy of 5-fluorouracil compared with other treatments among patients with actinic keratosis: A network meta-analysis.
    Wu Y; Tang N; Cai L; Li Q
    Dermatol Ther; 2019 May; 32(3):e12822. PubMed ID: 30638294
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reflectance confocal microscopy for noninvasive monitoring of therapy and detection of subclinical actinic keratoses.
    Ulrich M; Krueger-Corcoran D; Roewert-Huber J; Sterry W; Stockfleth E; Astner S
    Dermatology; 2010; 220(1):15-24. PubMed ID: 19907131
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment monitoring of 5-fluorouracil 0.5%/salicylic acid 10% lesion-directed therapy for actinic keratosis using dermoscopy and in-vivo reflectance confocal microscopy.
    Pampena R; Condorelli A; Cornacchia L; Guiducci L; Raucci M; Benati E; Mirra M; Peris K; Lai M; Pellacani G; Longo C
    Dermatol Ther; 2020 Jul; 33(4):e13744. PubMed ID: 32478958
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of low-dose 5-fluorouracil/salicylic acid in actinic keratoses in relation to treatment duration.
    Szeimies RM; Dirschka T; Prechtl A; Melzer A
    J Dtsch Dermatol Ges; 2015 May; 13(5):430-8. PubMed ID: 25918087
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Actikerall™ (5-Fluorouracil 0.5% and Salicylic Acid 10%) Topical Solution for Patient-directed Treatment of Actinic Keratoses.
    Nguyen HP; Rivers JK
    Skin Therapy Lett; 2016 May; 21(3):1-3. PubMed ID: 27223248
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recurrence rates and patient assessed outcomes of 0.5% 5-fluorouracil in combination with salicylic acid treating actinic keratoses.
    Stockfleth E; Zwingers T; Willers C
    Eur J Dermatol; 2012; 22(3):370-4. PubMed ID: 22494856
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-invasive monitoring of subclinical and clinical actinic keratosis of face and scalp under topical treatment with ingenol mebutate gel 150 mcg/g by means of reflectance confocal microscopy and optical coherence tomography: New perspectives and comparison of diagnostic techniques.
    Ruini C; Hartmann D; Bastian M; Ruzicka T; French LE; Berking C; von Braunmühl T
    J Biophotonics; 2019 Jul; 12(7):e201800391. PubMed ID: 30653833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term Efficacy of Topical Fluorouracil Cream, 5%, for Treating Actinic Keratosis: A Randomized Clinical Trial.
    Pomerantz H; Hogan D; Eilers D; Swetter SM; Chen SC; Jacob SE; Warshaw EM; Stricklin G; Dellavalle RP; Sidhu-Malik N; Konnikov N; Werth VP; Keri J; Lew R; Weinstock MA;
    JAMA Dermatol; 2015 Sep; 151(9):952-60. PubMed ID: 25950503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Topical treatment of actinic keratoses with low-dose 5-fluorouracil in combination with salicylic acid--pilot study.
    Schlaak M; Simon JC
    J Dtsch Dermatol Ges; 2010 Mar; 8(3):174-8. PubMed ID: 19889001
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reflectance confocal microscopy: non-invasive distinction between actinic keratosis and squamous cell carcinoma.
    Peppelman M; Nguyen KP; Hoogedoorn L; van Erp PE; Gerritsen MJ
    J Eur Acad Dermatol Venereol; 2015 Jul; 29(7):1302-9. PubMed ID: 25357235
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.